Condition: Chronic Kidney Diseases · Sponsor: Emory University
This study will test whether mindfulness meditation (MM) improves sympathetic function in chronic kidney disease (CKD) and whether transcutaneous vagus nerve stimulation (tVNS) optimizes the sympatho-inhibitory effects of mindfulness meditation (MM) and restores autonomic balance in CKD patients.
This description comes directly from the study's public registry record.
Jeanie Park, MD · 404-727-2525 · jeanie.park@emory.edu
Dana DaCosta · 404-727-7762 · drdacos@emory.edu
Always discuss trial participation with your own doctor first.
| Atlanta VA Medical Center | Atlanta, Georgia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04099992